Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Yinxingye is a traditional Chinese medicine (TCM) formulation primarily composed of Ginkgo biloba leaf extract and other herbal ingredients. It is most commonly available as "Fufang Yinxingye Pian" (compound ginkgo leaf extract tablet). The main mechanism of action is believed to involve improvement of cerebral blood flow, antioxidant effects, and neuroprotection. It has been studied for use in mild-to-moderate vascular dementia, where it may help improve cognitive function by reducing blood stasis and enhancing microcirculation in the brain[4]. The precise molecular mechanisms are not fully elucidated but are thought to include inhibition of platelet-activating factor, free radical scavenging, and modulation of neurotransmitter systems.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on fufang yinxingye.